TTRV122I and TTRV30M, the most prevalent amyloidogenic TTR mutations globally, are incompletely penetrant in some families and may not cause disease even in individuals homozygous for the pathogenic allele, while wild-type ATTR amyloidosis is exclusively a disease of late middle age and beyond. The gene discussed is TTR; the disease is amyloidosis.